Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.
企業コードZYBT
会社名Zhengye Biotechnology Holding Ltd
上場日Jan 07, 2025
最高経営責任者「CEO」Mr. Songlin Song
従業員数277
証券種類Ordinary Share
決算期末Jan 07
本社所在地No.1 Lianmeng Street, Jilin Economic &
都市JILIN
証券取引所NASDAQ Capital Market Consolidated
国China
郵便番号132101
電話番号
ウェブサイトhttps://www.jlzybio.com./
企業コードZYBT
上場日Jan 07, 2025
最高経営責任者「CEO」Mr. Songlin Song
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし